About Inivata
Inivata is a company based in Cambridge (United Kingdom) founded in 2014 was acquired by NeoGenomics in May 2021.. Inivata has raised $188.79 million across 6 funding rounds from investors including NeoGenomics, Janus Henderson Investors and Farallon Capital Management. The company has 81 employees as of December 31, 2020. Inivata operates in a competitive market with competitors including Guardant Health, GRAIL, Delfi Diagnostics, BillionToOne and Thrive Earlier Detection, among others.
- Headquarter Cambridge, United Kingdom
- Employees 81 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Inivata Limited
- Date of Incorporation 23 Jul, 2014
- Jurisdiction CAMBRIDGE, ENGLAND
-
Annual Revenue
$816.09 K (USD)-40as on Dec 31, 2022
-
Net Profit
$-53.8 M (USD)12as on Dec 31, 2022
-
EBITDA
$-53.8 M (USD)12as on Dec 31, 2022
-
Total Equity Funding
$188.79 M (USD)
in 6 rounds
-
Latest Funding Round
$35 M (USD), Series C
Feb 04, 2021
-
Investors
NeoGenomics
& 12 more
-
Employee Count
81
as on Dec 31, 2020
-
Acquired by
NeoGenomics
(May 05, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Inivata
Inivata has successfully raised a total of $188.79M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $35 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series C — $35.0M
-
First Round
First Round
(17 Sep 2014)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2021 | Amount | Series C - Inivata | Valuation | Soleus Capital | |
| May, 2020 | Amount | Series C - Inivata | Valuation | NeoGenomics |
|
| Aug, 2018 | Amount | Series B - Inivata | Valuation | RT Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Inivata
Inivata has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include NeoGenomics, Janus Henderson Investors and Farallon Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture capital and advisory services are offered across multiple sectors.
|
Founded Year | Domain | Location | |
|
Multiple sectors are targeted for venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Inivata
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Inivata
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Inivata Comparisons
Competitors of Inivata
Inivata operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Delfi Diagnostics, BillionToOne and Thrive Earlier Detection, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Provider of DNA sequencing for cancer detection
|
|
| domain | founded_year | HQ Location |
Provider of cell-free cancer liquid biopsy test
|
|
| domain | founded_year | HQ Location |
Blood-based liquid biopsy tests for multiple cancer detection are provided.
|
|
| domain | founded_year | HQ Location |
Non-invasive molecular diagnostic tests for cancer are developed using epigenetics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Inivata
Frequently Asked Questions about Inivata
When was Inivata founded?
Inivata was founded in 2014.
Where is Inivata located?
Inivata is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Is Inivata a funded company?
Inivata is a funded company, having raised a total of $188.79M across 6 funding rounds to date. The company's 1st funding round was a Series B of $52.81M, raised on Sep 17, 2014.
How many employees does Inivata have?
As of Dec 31, 2020, the latest employee count at Inivata is 81.
What is the annual revenue of Inivata?
Annual revenue of Inivata is $816.09K as on Dec 31, 2022.
What does Inivata do?
Inivata was founded in 2014 in Cambridge, United Kingdom, within the biotechnology sector. A liquid biopsy platform is provided by the company to detect cancer through next-generation sequencing. The proprietary TAm-Seq technology is employed to analyze large genomic regions, such as entire genes or exons, enhancing sensitivity and coverage beyond traditional approaches. Operations focus on a gene panel profiling 34 cancer-related genes for clinical applications.
Who are the top competitors of Inivata?
Inivata's top competitors include Guardant Health, GRAIL and BillionToOne.
Who are Inivata's investors?
Inivata has 13 investors. Key investors include NeoGenomics, Janus Henderson Investors, Farallon Capital Management, IP Group, and European Union.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.